Analysis of hepatitis C virus hypervariable region 1 sequence from cryoglobulinemia patients and associated controls

Journal of Virology

Volumn 81, Issue 9, 2007, Pages 4564-4571

  Bianchettin, Gabriella ^a   Bonaccini, Claudia ^b,e   Oliva, Romina ^b,f   Tramontano, Anna ^b   Cividini, Agostino ^a,c   Casato, Milvia ^b   Merlini, Giampaolo ^c   Silini, Enrico ^d   Mondelli, Mario U ^a,c  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF PARMA   (Italy)

^e UNIVERSITY OF FLORENCE   (Italy)

^f UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; RIBAVIRIN;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; BIOINFORMATICS; CHRONIC HEPATITIS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CRYOGLOBULINEMIA; GENE DELETION; GENE INSERTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MONOTHERAPY; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN MOTIF; STATISTICAL ANALYSIS; UNINDEXED SEQUENCE; VIRUS ENVELOPE;

AMINO ACID SEQUENCE; BASE SEQUENCE; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; CRYOGLOBULINEMIA; DNA PRIMERS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; ITALY; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; PRINCIPAL COMPONENT ANALYSIS; SEQUENCE ANALYSIS, DNA; VIRAL PROTEINS;

HEPATITIS C VIRUS;

EID: 34247592813     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02104-06     Document Type: Article

References (33)

1. Agnello, V., R. T. Chung, and L. M. Kaplan. 1992. A role for hepatitis C virus infection in type II cryoglobulinemia. N. Engl. J. Med. 327:1490-1493.
2. Alberti, A., L. Chemello, and L. Benvegnù. 1999. Natural history of hepatitis C. J. Hepatol. 31(suppl. 1): 17-24.
3. Alberti, A. 2005. Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanine aminotransferase levels. J. Hepatol. 42:266-274.
4. Ansaldi, F., B. Bruzzone, S. Salmaso, M. C. Rota, P. Durando, R. Gasparini, and G. Icardi. 2005. Different seroprevalencc and molecular epidemiology patterns of hepatitis C virus infection in Italy. J. Med. Virol. 76:327-332.
5. Booth, J. C., U. Kumar, D. Webster, J. Monjardino, and H. C. Thomas. 1998. Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients. Hepatology 26:223-227.
6. Brambilla, S., G. Bellati, M. Asti, A. Lisa, M. E. Candusso, M. D'Amico, G. Grassi, M. Giacca, A. Franchini, S. Bruno, G. Ideo, M. U. Mondelli, and E. M. Silini. 1998. Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease. Hepatology 27:1678-1686.
7. Casato, M., V. Agnello, L. P. Pucillo, G. B. Knight, M. Leoni, S. Del Vecchio, C. Mazzilli, G. Antonelli, and L. Bonomo. 1997. Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection. Blood 90:3865-3873.
8. Casato, M., C. Mecucci, V. Agnello, M. Fiorilli, G. B. Knight, C. Matteucci, L. Gao, and K. Jay. 2002. Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type 11 cryoglobulinemia. Blood 99:2259-2261.
9. Cox, T. 2005. An introduction to multivariate data analysis. Hodder Arnold, London, United Kingdom.
10. Crooks, G. E., G. Hon, J. M. Chandonia, and S. E. Brenner. 2004. WebLogo: a sequence logo generator. Genome Res. 14:1188-1190.
11. del Sol Mesa, A., F. Pazos, and A. Valencia. 2003. Automatic methods for predicting functionally important residues. J. Mol. Biol. 326:1289-1302.
12. Felsenstein, J. 1995. PHYLIP (phylogenetic inference package): version 3.57. Department of Genetics, University of Washington, Seattle.
13. Ferri, C., F. Caracciolo, and L. Zignego. 1994. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br. J. Haematol. 88:392-394.
14. Gerotto, M., F. Dal Pero, S. Loffreda, F. B. Bianchi, A. Alberti, and M. Lenzi. 2001. A 385 insertion in the hypervariable region 1 of hepatitis C virus E2 envelope protein is found in some patients with mixed cryoglobulinemia type 2. Blood 98:2657-2663.
15. Gobel, U., C. Sander, R. Schneider, and A. Valencia. 1994. Correlated mutations and residue contacts in proteins. Proteins 18:309-317.
16. Hermine, O., F. Lefrere, J. P. Bronowicki, X. Mariette, K. Jondeau, V. Eclache-Saudreau, B. Delmas, F. Valensi, P. Cacoub, C. Bréchot, B. Varet, and X. Troussard. 2002. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N. Engl. J. Med. 347:89-94.
17. Hofmann, W. P., E. Herrmann, B. Kronenberg, C. Merkwirth, C. Welsch, T. Lengauer, S. Zeuzem, and C. Sarrazin. 2004. Association of HCV-related mixed cryoglobulinemia with specific mutational pattern of the HCV E2 protein and CD81 expression on peripheral B lymphocytes. Blood 104:1228-1229.
18. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105-132.
19. Lunel, F., L. Musset, P. Cacoub, L. Frangeul, P. Cresta, M. Perrin, P. Grippon, C. Hoang, D. Valla, and J. C. Piette. 1994. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 106:1291-1300.
20. Mondelli, M. U., I. Zorzoli, A. Cerino, A. Cividini, M. Bissolati, L. Segagni, V. Perfetti, E. Anesi, P. Garini, and G. Merlini. 1998. Clonality and specificity of cryoglobulins associated with HCV: pathophysiological implications. J. Hepatol. 29:879-886.
21. Mondelli, M. U., A. Cerino, A. Lisa, S. Brambilla, L. Segagni, A. Cividini, M. Bissolati, G. Missale, G. Bellati, A. Meola, B. Bruni Ercole, A. Nicosia, G. Galfrè, and E. Silini. 1999. Antibody responses to hepatitis C virus hypervariable region I: evidence for cross-reactivity and immune-mediated sequence variation. Hepatology 30:537-545.
22. Penin, F., C. Combet, C. Germanidis, P. O. Frainais, G. Deleage, and J. M. Pawlotsky. 2001. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. J. Virol. 75:5703-5710.
23. Puoti, C., R. Castellacci, F. Montagnese, S. Zaltron, G. Stornaiuolo, N. Bergami, L. Bellis, D. F. Precone, P. Corvisieri, M. Puoti, E. Minola, and G. B. Gaeta. 2002. Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC). J. Hepatol. 37:117-123.
24. Rigolet, A., P. Cacoub, A. Schnuriger, L. Vallat, A. Cahour, P. Ghillani, F. Davi, Y. Benhamou, J. C. Piette, and V. Thibault. 2005. Genetic heterogeneity of the hypervariable region 1 of hepatitis C virus and lymphoproliferative disorders. Leukemia 19:1070-1076.
25. Rosa, D., G. Saletti, E. De Gregorio, F. Zorat, C. Comar, U. D'Oro, S. Nuti, M. Houghton, V. Barnaba, G. Pozzato, and S. Abrignani. 2005. Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc. Natl. Acad. Sci. USA 102: 18544-18549.
26. Saitou, N., and M. Nei. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
27. Schneider, T. D., and R. M. Stephens. 1990. Sequence logos: a new way to display consensus sequences. Nucleic Acids Res. 18:6097-6100.
28. Silini, E., F. Bono, A. Cividini, A. Cerino, S. Bruno, S. Rossi, G. Belloni, B. Brugnetti, E. Civardi, L. Salvaneschi, and M. U. Mondelli. 1995. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology 21:285-290.
29. Simmonds, P., J. Bukh, C. Combet, G. Deléage, N. Enomoto, S. Feinstone, P. Halfon, G. Inchauspé, C. Kuiken, G. Maertens, M. Mizokami, D. G. Murphy, H. Okamoto, J.-M. Pawlotsky, F. Penin, E. Sablon, T. Shin-I, L. J. Stuyver, H.-J. Thiel, S. Viazov, A. J. Weiner, and A. Widell. 2005. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962-973.
30. Suarez, F., O. Lortholary, O. Hermine, and M. Lecuit. 2006. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 107:3034-3044.
31. Yoshioka, K., T. Aiyama, A. Okomura, M. Takayanagi, K. Iwata, T. Ishikawa, Y. Nagai, and S. Kakumu. 1997. Humoral immune response to the hypervariable region of hepatitis C virus differs between genotype 1b and 2a. J. Infect. Dis. 175:505-510.
32. Zehender, G., C. De Maddalena, F. Bernini, E. Ebranati, G. Monti, P. Pioltelli, and M. Galli. 2005. Compartmentalization of hepatitis C virus quasispecies in blood mononuclear cells of patients with mixed cryoglobulinemic syndrome. J. Virol. 79:9145-9156.
33. Zuckerman, E., T. Zuckerman, A. M. Levine, D. Douer, K. Gutekunst, M. Mizokami, D. G. Quian, M. Velankar, B. N. Nathwani, and T. L. Fong. 1997. Hepatitis C virus infection in patients with B cell non-Hodgkin's lymphoma. Ann. Intern. Med. 127:423-438.